Drawing for AURIOCEL

USPTO serial 99461749

AURIOCEL

Reviewed by CopyMark Law Group

Status 774
Filing date
Status date
Registration date
—
Examiner
LOREDO GASPAR,ALONSO
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AURIOCEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

SEAN KENNETH OWENS

SEAN KENNETH OWENS WOOD HERRON & EVANS LLP600 VINE STREETSUITE 2800CINCINNATI, OH 45202

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products in the nature of pharmaceutical preparations for the treatment, alleviation and healing of eye diseases, namely, the limbal stem cell deficiency in the corneal and limbal areaACTIVE—
042Development of pharmaceutical preparations and substances in the nature of medicines; scientific and technological services in the nature of analysis and research in the field of pharmaceuticals; industrial analysis and research services, namely, industrial research in the field of pharmaceuticals and scientific and technological analysis in the field of pharmaceuticalsACTIVE—
044Medical servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 19, 2026ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Aug 19, 2026OP.IOPPOSITION INSTITUTED NO. 999999—
May 21, 2026ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Apr 21, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 21, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 15, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 26, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 25, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 25, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 25, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 12, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 12, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 12, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 11, 2026DOCKASSIGNED TO EXAMINER—
Feb 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 24, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 24, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance